Product image of Migard (Frovatriptan) supplied by GNH India

Migard

Active Ingredient:
Frovatriptan
Origin:
EU

Migard (Frovatriptan)

Frovatriptan, the active ingredient in Migard, is a Triptan presented as a 2.5 mg tablet for oral use. It is classified as an antimigraine agent (ATC code N02CC04) and is indicated for the acute treatment of migraine attacks, including migraine with aura, in adult patients.

GNH India supplies Migard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Manufacturer / TM Owner

Menarini International Operations Luxembourg S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Frovatriptan acts on the migraine pathway as a selective 5‑HT1B/1D receptor agonist.

  • Acute migraine attack: provides rapid relief of headache and associated symptoms.
  • Migraine with aura: reduces headache severity when aura precedes the attack.
  • Menstrual migraine (short‑term prevention): may be used to lessen migraine frequency around menstruation.

How It Works

  • Frovatriptan selectively stimulates serotonin 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and trigeminal nerve endings. Activation of 5‑HT1B receptors induces cranial vasoconstriction, while 5‑HT1D stimulation inhibits release of vasoactive neuropeptides such as CGRP, thereby aborting the migraine cascade.

Side Effects

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Dizziness: transient light‑headedness.
  • Fatigue: feeling of tiredness or weakness.
  • Dry mouth: reduced salivation.
  • Somnolence: mild sleepiness.
  • Chest discomfort: mild pressure or tightness.

Serious or Rare Side Effects

  • Coronary vasospasm: severe chest pain requiring medical attention.
  • Myocardial infarction: heart attack symptoms.
  • Serotonin syndrome: agitation, hyperthermia, tremor.
  • Severe hypertension: sudden high blood pressure.
  • Allergic reactions: rash, swelling, anaphylaxis.
  • Cardiac arrhythmias: irregular heart rhythm.

Precautions & Warnings

Before using Migard, consider the following precautions:

  • Cardiovascular disease: avoid if you have coronary artery disease, angina, or uncontrolled hypertension.
  • History of stroke or TIA: contraindicated in patients with prior cerebrovascular events.
  • Concomitant triptans or ergotamines: do not combine with other migraine-specific agents.
  • Pregnancy Category C: discuss risks with a healthcare professional before use.
  • Hepatic impairment: use with caution; dose adjustment may be required.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Frovatriptan may interact with several medicines.

Major Interactions (Avoid)

  • MAO inhibitors: increase risk of serotonin syndrome.
  • SSRIs/SNRIs: combined use can precipitate serotonin toxicity.
  • Other triptans or ergot alkaloids: additive vasoconstrictive effects.
  • Strong CYP3A4 inhibitors: may raise frovatriptan plasma levels.

Moderate Interactions (Monitor Closely)

  • NSAIDs: concurrent use may raise risk of gastrointestinal bleeding.
  • Antihypertensives: may reduce blood‑pressure‑lowering efficacy.
  • Oral contraceptives: may influence migraine frequency; monitor symptom changes.

Frequently Asked Questions

Migard contains frovatriptan, a prescription‑only triptan indicated for the acute treatment of migraine attacks, including migraine with aura, in adult patients.

Frovatriptan selectively activates serotonin 5‑HT1B and 5‑HT1D receptors, causing cranial blood‑vessel constriction and blocking release of pain‑triggering neuropeptides, which helps stop a migraine once it has started.

The prescribed dose of Migard is determined by the treating physician based on individual clinical assessment and local prescribing guidelines.

Migard is classified as Pregnancy Category C, meaning risk cannot be ruled out. Use only if the potential benefit justifies the risk, and discuss breastfeeding considerations with a healthcare professional.

Submit an enquiry on the Migard product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Migard (frovatriptan) has a longer half‑life than many other triptans, offering sustained migraine relief and a lower recurrence rate, while maintaining a safety profile comparable to other agents in the class.

Store Migard tablets below 25 °C in the original container, protected from moisture and direct sunlight. Keep out of reach of children.

Migard is taken orally as a single tablet at the onset of a migraine attack. Swallow the tablet whole with water; do not crush or chew.

Serious risks include coronary vasospasm, myocardial infarction, severe hypertension, serotonin syndrome, and rare allergic reactions such as anaphylaxis. Seek immediate medical attention if these occur.

Migard should not be used by patients with uncontrolled cardiovascular disease, a history of stroke or transient ischemic attack, severe hepatic impairment, or those taking other triptans, ergotamines, or MAO inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.